Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core Scientific Inc (CORZ) vs Cytokinetics Inc (CYTK) Price & Performance

Core Scientific IncTrade
Cytokinetics IncTrade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs Cytokinetics Inc — how do they compare? Core Scientific Inc trades at $22.26 (market cap $7.02B), while Cytokinetics Inc trades at $81.99 (market cap $11.12B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.

CORZCYTK
Market Cap
$7.02B$11.12B
Sector
TechnologyTechnology
52-Week High
$29.16$87.26
52-Week Low
$12.65$33.23
Enterprise Value
$8.07B$11.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core Scientific Inc

Core Scientific (CORZ) trades at $22.71, down 3.32% today, with a bearish technical signal despite strong analyst support. The company is transitioning from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. However, the company continues to report significant losses with a net income margin of -341.68% and negative cash flow of $525.6M in 2025.

The outlook remains speculative with substantial execution risk despite analyst optimism. While the AI pivot offers growth potential, persistent losses and cash burn present significant challenges. The consensus price target of $34.17 suggests 50% upside potential, but investors must weigh the high-risk transformation against the company's current financial instability.

Cytokinetics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

Read more on CORZ

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK